Cystic Teratoma


Continuing Education Activity

Cystic teratoma is the most common ovarian neoplasm. It consists of well-differentiated derivatives of germ cell layers (i.e., ectoderm, mesoderm, and endoderm) developing as hair, muscle, teeth, or bone. These tumors are generally benign but may undergo a malignant transformation in 1% to 2% of the cases. Due to their higher incidence in females between ages 20 and 40, and the risk of complications particularly torsion, it is important to treat them by surgical removal. This activity reviews the evaluation and treatment of cystic teratomas and highlights the role of the interprofessional team in evaluating and treating patients with this condition.

Objectives:

  • Identify the etiology of cystic teratoma.
  • Review the evaluation of cystic teratoma.
  • Outline the management options available for cystic teratoma.

Introduction

Cystic teratoma is a type of germ cell tumor that contains well-differentiated tissues developed from three germ cell layers (ectoderm, mesoderm, and endoderm). The earliest evidence of teratoma dates back to as old as 2000 years B.C. The first case of MCT was reported by Johannes Scultetus in 1659 while recording the autopsy findings of a young woman who died of an ovarian tumor described as a “dermoid cyst of the ovary.”[1] In 1863, Rudolf Virchow introduced the term “teratoma,” derived from the Greek word “teras,” meaning monster.[2] 

Ovarian teratomas are broadly classified histologically into monodermal teratomas (carcinoid tumors, neural tumors, struma ovarii), immature teratomas, and mature cystic teratomas. The most common type among these tumors is mature cystic teratoma, also known as "Dermoid cyst." Cystic teratomas constitute about 20% of ovarian germ cell tumors. The most common site of occurrence is in the ovaries and testes. However, they can rarely be seen in the anterior mediastinum, sacrococcygeal region, or neck. Mature cystic teratoma is always benign with a slow growth rate of 1.8 mm/year; however, in rare circumstances, it can undergo malignant transformation. 

Etiology

Multiple studies have identified some risk factors that have been linked to mature cystic teratomas. They include the following: late menarche with menstrual irregularities, alcohol abuse, history of cystic teratoma in the past, fewer pregnancies, infertility, exercise during adolescence (related to anovulatory menstrual cycles).[3]

Epidemiology

Cystic teratomas are the most common ovarian germ cell tumors comprising 20% of all the ovarian tumors in adults and half of all ovarian neoplasms in children and are usually benign. On the contrary, malignancy is a rare occurrence constituting about 1%.[4][5] They are most predominant in women in their second and third decades of life as the most common benign tumor less than 45 years of age. According to one of the largest studies involving 460,000 females, it was observed that the annual incidence rate of CT was 1.2 to 14.2 cases per 100,000.[6][3] 

Over the period of decades, several multicenter studies have observed different rates of incidence of benign cystic teratomas such as Marchetti observed a 20% occurrence of all ovarian tumors, while a large study by Blackwell et al. reported the occurrence to be 5%. Due to the rarity of this tumor, literature is skewed by either isolated case reports or small multicenter groups of cases. Thus leading to a broader range of incidence.

Pathophysiology

Since the discovery of grotesque teratoma lesions which resembled deformed fetus, several theories emerged based on concepts from religious to scientific assumptions. Some of the interesting ideas involved the likely cause of witchcraft, perverted gestation, immoral acts, and ingestion of hair and bones embedded in the ovaries. It was later believed that these tumors originated from degenerated ova, in situ impregnation of ovum within the ovary (fetus in the fetus). Evidence of dermoid cyst in virgins, post-menopausal women, males, and extra ovarian sites (stomach, mediastinum) convinced the biologists that structures like bone, teeth could develop within a tumor instead of its origin as a result of aberrant fertilization.[2] 

Analysis of biochemical and cytogenetic data showed that cystic teratomas of the ovary are parthenogenetic tumors formed by spontaneous asexual development of an unfertilized ovum after the first meiotic division. Another explanation is the alteration of blastodermal elements in a fertilized ovum. Despite all these theories, the pathophysiology of teratoma formation is still obscure and the focus of many experimental studies.[7] An extraordinary feature of the teratoma is its ability to not only differentiate into tissue cells but also develop into organ systems. For example, respiratory epithelium with blocks of cartilage and bone fragments developing into digits or partial limb at rare instances.[8]

Histopathology

Mature cystic teratomas are unilocular in  88% of the cases with a cystic cavity lined by squamous epithelium. The cyst is predominantly filled with sebaceous material that is liquid at body temperature and solidifies at room temperature. The size of these tumors varies from very tiny cystic masses to as large as greater than 39cm, with 80% measuring 10cm or less.[9] These tumors are most frequently unilateral, involving the right ovary (72%), and bilateral in 12%.[4] 

On gross appearance, these lesions do not have a characteristic shape or size as it depends on the microscopic heterogeneity of the contents. Hair, teeth, and bones are easily identifiable on gross examination. Microscopic examination of the contents confirms the diagnosis by identifying tissues derived from the following germ cell layers: Ectodermal tissue (epithelium and neural tissue), Mesodermal tissue (muscle, fat, bone, cartilage), and endodermal tissue ( thyroid tissue, gastrointestinal epithelium).[10]

History and Physical

Cystic teratomas are usually asymptomatic or can have minimal symptoms. Various studies have reported asymptomatic tumor rates to be 6-65% at the time of diagnosis. They are often discovered as an incidental finding on radiographic studies, during a physical exam or pelvic/abdominal surgery for any other pathology. The next most common symptom reported at the time of presentation is lower abdominal pain with a reported rate of 44 to 47%, followed by palpable abdominal or pelvic mass.[11] 

Some patients present with increasing abdominal girth. Gastrointestinal or urinary symptoms can develop with increasing tumor size causing compression or invasion of the adjacent structures. Symptoms like fever, cachexia, severe abdominal pain, vaginal bleeding can also occur in advanced disease.[12] 

In the case of ovarian torsion, one of the most common complications of cystic teratoma, the patient presents with an acute abdomen (sudden abdominal pain, nausea, vomiting), requiring urgent management. On physical examination, bimanual palpation of the ovaries to determine the presence or absence of adnexal masses, uterus size, and abdominal tenderness should be assessed. Therefore, a detailed history with more emphasis on gynecological history and a thorough physical exam, abdominal and pelvic exam, in particular, plays a crucial role in early diagnosis and management of a patient presenting with the above symptoms.

Evaluation

Initial Assessment: It involves an initial assessment of the patient, including vitals, detailed history, physical exam with more emphasis on abdominal and pelvic exam, followed by complete blood count, complete metabolic panel, and a pregnancy test. Mature cystic teratomas do not have any specific diagnostic tumor marker.  Serum tumor markers, in particular, alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and lactate dehydrogenase (LDH) have shown to play some role in diagnosis and follow up. Cystic teratomas are usually asymptomatic and often discovered on workup for other conditions. However, in patients presenting with abdominal pain, discomfort, and increasing abdominal girth, imaging plays an important role in further workup. 

Imaging: Although plain radiographs may show radiopaque bodies due to calcifications during work-up for urinary or intestinal pathology, cysts with very little or no calcification can be easily missed. Ultrasound is the preferred initial radiological investigation for the evaluation of adnexal mass. Cystic teratoma appears as a heterogeneous mass with echogenic focus causing acoustic shadowing due to calcification, sebum, and hair. Fat fluid and hair fluid levels are more specific features. Some other peculiar sonographic findings include the Rokitansky nodule, iceberg sign, dot-dash pattern(dermoid mesh), and floating balls sign. Transvaginal ultrasound is superior to abdominal ultrasound for screening for cystic teratomas with a sensitivity of 57.9% and specificity of 99.7%. It has proven to be as accurate as MRI in the identification and characterization of ovarian cystic teratomas.[13][14] 

In torsion, a whirlpool sign with a twisted vascular pedicle is seen on color Doppler ultrasound.[15] Ovarian teratomas can also be overlooked on abdominal ultrasound if it appears similar to bowel gas. CT abdomen and pelvis is believed to be the best modality for evaluation of an adnexal mass, especially for pre-operative assessment.[16] 

Histopathological evaluation remains the gold standard for diagnosis.

Treatment / Management

The definitive treatment of cystic teratoma is surgery. Due to the highest incidence of cystic teratomas in women of reproductive age, the major concern is preserving fertility and minimizing post-surgical adhesion formation. Size of the mass, ultrasound characteristics, involvement of adjacent structures, risk of malignancy, and most importantly, patient’s symptoms and wish to retain fertility are factors determining the best management plan. Options include the following:

Surveillance: Pre-menopausal women who wish to be pregnant and have a cyst size of lower than 6cm are recommended conservative management for as long as the growth rate of the cyst is <2cm/year. In cystic teratoma during pregnancy, surveillance is recommended as far as the patient is not having acute symptoms.[17][18]

Surgical management: In premenopausal women, symptomatic dermoid lesions less than 5 cm are preferably removed by simple laparoscopic cystectomy, rather than removing the entire ovary. Cysts larger than 5 to 6 cm and have involved the entire ovary with distortion of its structure should be removed by oophorectomy. Oophorectomy should be considered in postmenopausal women with multiple cysts. Histological examination of the surgical specimen confirms the diagnosis, including staging in case of carcinoma. In such cases, complete resection with bilateral salpingo-oophorectomy, hysterectomy, and even platinum-based chemotherapy is the mainstay of treatment.[19] Laparoscopy is the gold standard technique for surgical management. 

Laparoscopic surgery has a diagnostic advantage in which peritoneal liquid sampling and exploration of the abdominopelvic cavity for possible malignancy can be done to assess the involvement of adjacent structures.[20] Laparotomy is recommended in complex cases like massive complex mass, cyst rupture with an acute emergency, or malignancy with advanced stage. When suspicion of malignant transformation is high, management includes a frozen section analysis of the tissue specimen by a pathologist during the surgery.

Laparotomy may be given priority over the laparoscopic approach if there is a risk of spillage of cyst contents. As soon as the pathological diagnosis of malignancy is established, the next step is to complete tumor excision with staging to determine prognosis and further treatment.[21] Intraoperative spillage of cystic teratoma contents has an estimated incidence of 0.2% with laparoscopic excision of the mass. Chemical irritation by the contents can increase the risk of adhesion formation. The use of Endobag (impermeable endoscopic sac) in one randomized controlled trial demonstrated a reduction of spillage from 46% to 3.7% of the cases.[22] Recurrence risk post laparoscopic cystectomy has also been observed, ranging from 2 to 10 years after surgery. Due to the risk of involvement of the contralateral ovary with occult cystic teratoma, careful inspection of the ovary is essential. Some patients also develop other germ cell tumors seen from 6 months to 6 years. Therefore, premenopausal patients managed with cystectomy should be followed for recurrence and other germ cell tumors.[22][23]

Differential Diagnosis

Differential Diagnosis of cystic teratoma encompasses broad categories of conditions depending on the origin and pathological nature of the mass. The classification is based on its appearance as an adnexal mass. It is as follows: 

Non-gynecological

  1. Benign: Renal cyst, peritoneal cyst, bladder diverticulum, pelvic kidney, peritoneal inclusion cyst, diverticular abscess, peritoneal/retroperitoneal abscess.
  2. Malignant: retroperitoneal sarcoma, metastasis (lung, lymphoma, etc.), gastrointestinal cancer. 

Gynecological

  1. Benign: ectopic pregnancy, hemorrhagic ovarian cyst, tubo-ovarian abscess, pedunculated fibroid, polycystic ovary, simple cyst, endometrioma, cystadenoma.
  2. Malignant: Endometrial carcinoma, ovarian sarcoma, sex cord/stromal tumor, ovarian germ cell tumor, Kruckenberg tumor.

Prognosis

Prognosis largely depends upon the extent of the disease and its complications. Benign cystic teratomas generally have an excellent prognosis after surgical management with some risk of recurrence in 2 to 10 years. On the contrary cystic teratomas with malignant transformation have variable outcomes depending upon the stage, growth pattern, and vascular invasion of the tumor.[24] According to one study by Peterson et al. 75%, the 5-year survival rate was seen in unruptured stage I tumors.[1] Pooled data by Kashimura et al. showed a 5-year survival rate in stage I: 50%, 5-year survival rate in stage II: 25%, 5-year survival rate in stage III: 12%, and no survivors in stage IV.[25]

Complications

Ovarian cystic teratomas can be associated with a wide spectrum of complications. Timely and accurate diagnosis significantly reduces morbidity and mortality. Common complications of cystic teratomas are listed below;

  1. Torsion: One of the well-established complications of ovarian tumors is its rotation around the pedicle (supportive ligament), compromising its own blood flow leading to gangrenous or hemorrhagic infarction. The torsion incidence ranges from 3 to 21 %, most commonly occurring in the group 5 to 15 cm in size.[2][26] Intermediate sized teratomas are more prone to torsion as compared to small or large ones. Mild twisting along the pedicle can also affect venous drainage resulting in congestion and ultimately hemorrhage within the cyst itself.
  2. Rupture: Although not a very common occurrence, the risk of rupture is 1 to 4% in ovarian teratomas. Leakage of contents of the cyst-like sebaceous fluid, desquamated epithelial cells, bone, or teeth into the peritoneal cavity can lead to acute or chronic peritonitis.[13] Rupture of the cyst into adjacent structures like the intestine or rectum may result in bone expulsion, hair, and teeth via the anus.
  3. Infection: The risk of infection in cystic teratoma is about 1 to 4%. The route of infection can be hematogenous, lymphomatous, or by direct extension from the adjacent structures like intestines. Infection can also predispose the cyst to form adhesions or even rupture in severe cases.[26] 
  4. Adhesions: Occasionally, the cyst may become dependant on the blood supply of the omentum or surrounding structures by forming contralateral circulation and completely get detached from its pedicle, hence called “parasitic dermoid.” Chronic inflammation can lead to a worsening of adhesions, increasing the risk of intestinal obstruction.
  5. Malignant transformation:  Malignant transformation has been reported to occur in 1 to 3% of all cases of cystic teratoma between 30 and 70 years of age, with a higher incidence in patients between 40 to 60 years of age. Of those, squamous cell carcinoma was the most common (50%).[27] The other 50% involved transitional cell carcinoma, malignant melanoma, choriocarcinoma, carcinoids, sarcomas, and adenocarcinoma. Patients with tumor size >10mm were seen to be at higher risk of developing malignant transformation.[24][28] Limited capsular malignancy has a better prognosis.
  6. Gliomatosis peritonei: Implantation of glial tissue on the visceral or peritoneal lining in a metastatic manner appear as grey or white nodules, 1 to 3 mm in diameter, and are scattered throughout the peritoneal cavity. Due to their indistinguishable appearance from peritoneal carcinomatosis and tuberculous peritonitis, histological evaluation is necessary for diagnosis.[29] 
  7. Anti-N-methyl-D-aspartate receptor (NMDAR)encephalitis: An infrequent auto-immune complication may occur with neuropsychiatric symptoms. Anti-NMDAR antibodies target NMDA receptors resulting in the progressive decline of synaptic functions. Early recognition and prompt treatment with surgery improve the clinical outcome.[30]

Postoperative and Rehabilitation Care

Minimally invasive procedures like laparoscopy have reduced postoperative pain, hospital length of stay, and markedly less blood loss versus laparotomy, hence, early mobilization and quick recovery. Post-operative counseling regarding incision care, diet, pain management, and extent of physical activity determine the course of the patient's natural recovery.

Consultations

The management of cystic teratoma involves a multidisciplinary healthcare team with the following specialties:

  • Radiology
  • Obstetrics/gynecology
  • Surgery
  • Pathology
  • Oncology

Deterrence and Patient Education

Patient counseling begins the moment the patient presents with signs and symptoms of the disease. Before choosing the treatment plan, the advantages, and disadvantages of all treatment modalities should be discussed in detail along with prognosis and potential complications. In premenopausal women who wish to have children in the future, the management focuses on preserving ovarian tissue with minimal adhesion formation and regular follow up visits.

Enhancing Healthcare Team Outcomes

Although cystic teratomas are benign tumors, the development of malignancy or complications(torsion, adhesions, rupture, infection), it can rapidly turn into a life-threatening condition with higher morbidity and mortality. Therefore early recognition and appropriate treatment is the most important part of management. A multidisciplinary healthcare team involving surgeon, gynecologist, radiologist, oncologist working together to plan a patient-centered treatment strategy leads to improved patient outcomes. Based on available data, a thorough preoperative risk assessment, surgical cytoreduction, and adjuvant platinum-based therapy with whole pelvic radiation for the early-stage disease have shown some beneficial effects.[21]


Article Details

Article Author

Arooj Ahmed

Article Editor:

Saran Lotfollahzadeh

Updated:

6/2/2021 9:55:58 AM

PubMed Link:

Cystic Teratoma

References

[1]

PETERSON WF, Malignant degeneration of benign cystic teratomas of the overy; a collective review of the literature. Obstetrical     [PubMed PMID: 13493921]

[2]

Pantoja E,Noy MA,Axtmayer RW,Colon FE,Pelegrina I, Ovarian dermoids and their complications. Comprehensive historical review. Obstetrical     [PubMed PMID: 1089224]

[3]

Westhoff C,Pike M,Vessey M, Benign ovarian teratomas: a population-based case-control study. British journal of cancer. 1988 Jul;     [PubMed PMID: 3166898]

[4]

Saba L,Guerriero S,Sulcis R,Virgilio B,Melis G,Mallarini G, Mature and immature ovarian teratomas: CT, US and MR imaging characteristics. European journal of radiology. 2009 Dec;     [PubMed PMID: 18804932]

[5]

MATZ MH, Benign cystic teratomas of the ovary. A review. Obstetrical     [PubMed PMID: 14471483]

[6]

Gadducci A,Guerrieri ME,Cosio S, Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists. Critical reviews in oncology/hematology. 2019 Jan     [PubMed PMID: 30661663]

[7]

Linder D,McCaw BK,Hecht F, Parthenogenic origin of benign ovarian teratomas. The New England journal of medicine. 1975 Jan 9;     [PubMed PMID: 162806]

[8]

Ashley DJ, Origin of teratomas. Cancer. 1973 Aug;     [PubMed PMID: 4722920]

[9]

Caruso PA,Marsh MR,Minkowitz S,Karten G, An intense clinicopathologic study of 305 teratomas of the ovary. Cancer. 1971 Feb;     [PubMed PMID: 5100397]

[10]

Outwater EK,Siegelman ES,Hunt JL, Ovarian teratomas: tumor types and imaging characteristics. Radiographics : a review publication of the Radiological Society of North America, Inc. 2001 Mar-Apr;     [PubMed PMID: 11259710]

[11]

Ayhan A,Bukulmez O,Genc C,Karamursel BS,Ayhan A, Mature cystic teratomas of the ovary: case series from one institution over 34 years. European journal of obstetrics, gynecology, and reproductive biology. 2000 Feb;     [PubMed PMID: 10690674]

[12]

Goudeli C,Varytimiadi A,Koufopoulos N,Syrios J,Terzakis E, An ovarian mature cystic teratoma evolving in squamous cell carcinoma: A case report and review of the literature. Gynecologic oncology reports. 2017 Feb;     [PubMed PMID: 28050596]

[13]

Srisajjakul S,Prapaisilp P,Bangchokdee S, Imaging features of unusual lesions and complications associated with ovarian mature cystic teratoma. Clinical imaging. 2019 Sep - Oct;     [PubMed PMID: 31212220]

[14]

Sahin H,Abdullazade S,Sanci M, Mature cystic teratoma of the ovary: a cutting edge overview on imaging features. Insights into imaging. 2017 Apr     [PubMed PMID: 28105559]

[15]

Mais V,Guerriero S,Ajossa S,Angiolucci M,Paoletti AM,Melis GB, Transvaginal ultrasonography in the diagnosis of cystic teratoma. Obstetrics and gynecology. 1995 Jan;     [PubMed PMID: 7800323]

[16]

Buy JN,Ghossain MA,Moss AA,Bazot M,Doucet M,Hugol D,Truc JB,Poitout P,Ecoiffier J, Cystic teratoma of the ovary: CT detection. Radiology. 1989 Jun;     [PubMed PMID: 2717741]

[17]

Sinha A,Ewies AA, Ovarian Mature Cystic Teratoma: Challenges of Surgical Management. Obstetrics and gynecology international. 2016;     [PubMed PMID: 27110246]

[18]

Ganer Herman H,Sagiv R,Raphaeli H,Kerner R,Keidar R,Bar J,Ginath S, Surgical treatment of mature cystic teratomas: A comparison of emergent and elective surgeries. The journal of obstetrics and gynaecology research. 2017 Jan     [PubMed PMID: 27935160]

[19]

Gadducci A,Giuliani D,Cosio S,Lissoni A,Ferrero AM,Landoni F, Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study. Anticancer research. 2019 May;     [PubMed PMID: 31092447]

[20]

Chapron C,Dubuisson JB,Samouh N,Foulot H,Aubriot FX,Amsquer Y,Morice P, Treatment of ovarian dermoid cysts. Place and modalities of operative laparoscopy. Surgical endoscopy. 1994 Sep;     [PubMed PMID: 7992183]

[21]

Dos Santos L,Mok E,Iasonos A,Park K,Soslow RA,Aghajanian C,Alektiar K,Barakat RR,Abu-Rustum NR, Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecologic oncology. 2007 May;     [PubMed PMID: 17240432]

[22]

Templeman CL,Fallat ME,Lam AM,Perlman SE,Hertweck SP,O'Connor DM, Managing mature cystic teratomas of the ovary. Obstetrical     [PubMed PMID: 11128910]

[23]

Anteby EY,Ron M,Revel A,Shimonovitz S,Ariel I,Hurwitz A, Germ cell tumors of the ovary arising after dermoid cyst resection: a long-term follow-up study. Obstetrics and gynecology. 1994 Apr;     [PubMed PMID: 8134074]

[24]

Rathore R,Sharma S,Arora D, Clinicopathological Evaluation of 223 Cases of Mature Cystic Teratoma, Ovary: 25-Year Experience in a Single Tertiary Care Centre in India. Journal of clinical and diagnostic research : JCDR. 2017 Apr;     [PubMed PMID: 28571142]

[25]

Kashimura M,Shinohara M,Hirakawa T,Kamura T,Matsukuma K, Clinicopathologic study of squamous cell carcinoma of the ovary. Gynecologic oncology. 1989 Jul;     [PubMed PMID: 2737532]

[26]

PETERSON WF,PREVOST EC,EDMUNDS FT,HUNDLEY JM Jr,MORRIS FK, Benign cystic teratomas of the ovary; a clinico-statistical study of 1,007 cases with a review of the literature. American journal of obstetrics and gynecology. 1955 Aug;     [PubMed PMID: 13238472]

[27]

[Incidence of caries in molars and its local prevention]., BorovskiÄ­ EV,Leus PA,Terent'eva GB,Kobishchan SI,Borovskaia NV,, Stomatologiia, 1977 Nov-Dec     [PubMed PMID: 28657230]

[28]

Rim SY,Kim SM,Choi HS, Malignant transformation of ovarian mature cystic teratoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2006 Jan-Feb;     [PubMed PMID: 16445624]

[29]

Robboy SJ,Scully RE, Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Human pathology. 1970 Dec;     [PubMed PMID: 5521737]

[30]

Dalmau J,Gleichman AJ,Hughes EG,Rossi JE,Peng X,Lai M,Dessain SK,Rosenfeld MR,Balice-Gordon R,Lynch DR, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet. Neurology. 2008 Dec;     [PubMed PMID: 18851928]